Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol zentiva 0.5 mg tabletten
helvepharm ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 0.5 mg corresp. pramipexolum 0.35 mg, betadexum, maydis amylum, povidonum k 30, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol zentiva 1.5 mg tabletten
helvepharm ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 1.5 mg corresp. pramipexolum 1.1 mg, betadexum, maydis amylum, povidonum k 30, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol mylan 1.5 mg tabletten
mylan pharma gmbh - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 1,5 mg endwerte. pramipexolum 1,1 mg, excipiens pro compresso. - morbus parkinson, symptomatische behandlung des idiopathischen restless legs syndroms (rls) - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol stada 0.125 mg tabletten
spirig healthcare ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 0,125 mg endwerte. pramipexolum 0.088 mg, excipiens pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol stada 0.25 mg tabletten
spirig healthcare ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 0,25 mg endwerte. pramipexolum 0.18 mg, excipiens pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol stada 0.5 mg tabletten
spirig healthcare ag - pramipexolum - tabletten - pramipexoli dihydrochloridum monohydricum 0,5 mg endwerte. pramipexolum 0,35 mg, excipiens pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol-mepha er 0.375 mg depotabs
mepha pharma ag - pramipexolum - depotabs - pramipexoli dihydrochloridum monohydricum 0.375 mg corresp. pramipexolum 0.26 mg, hypromellosum, calcii hydrogenophosphas, magnesii stearas, silica colloidalis anhydrica pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol-mepha er 0.75 mg depotabs
mepha pharma ag - pramipexolum - depotabs - pramipexoli dihydrochloridum monohydricum 0.750 mg corresp. pramipexolum 0.52 mg, hypromellosum, calcii hydrogenophosphas, magnesii stearas, silica colloidalis anhydrica pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol-mepha er 1.5 mg depotabs
mepha pharma ag - pramipexolum - depotabs - pramipexoli dihydrochloridum monohydricum 1.500 mg corresp. pramipexolum 1.05 mg, hypromellosum, calcii hydrogenophosphas, magnesii stearas, silica colloidalis anhydrica pro compresso. - morbus parkinson - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
pramipexol-mepha er 3 mg depotabs
mepha pharma ag - pramipexolum - depotabs - pramipexoli dihydrochloridum monohydricum 3.000 mg corresp. pramipexolum 2.1 mg, hypromellosum, calcii hydrogenophosphas, magnesii stearas, silica colloidalis anhydrica pro compresso. - morbus parkinson - synthetika